Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
MarketBeat: Week in Review 11/21 - 11/25
See the World with Dollar Flight Club's Lowest Price for Black Friday Weekend
See how to make money instead of spending it on Black Friday with this offer (Ad)
Arrival, Coupa Software rise; Apple, Activision fall
Inflation hovers over shoppers seeking deals on Black Friday
THE BEST BLACK FRIDAY DEAL YET (Ad)
Mexico's domestic airline industry in shambles
Macao awards casino licenses to MGM, Sands, Wynn, 3 others
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
MarketBeat: Week in Review 11/21 - 11/25
See the World with Dollar Flight Club's Lowest Price for Black Friday Weekend
See how to make money instead of spending it on Black Friday with this offer (Ad)
Arrival, Coupa Software rise; Apple, Activision fall
Inflation hovers over shoppers seeking deals on Black Friday
THE BEST BLACK FRIDAY DEAL YET (Ad)
Mexico's domestic airline industry in shambles
Macao awards casino licenses to MGM, Sands, Wynn, 3 others
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
MarketBeat: Week in Review 11/21 - 11/25
See the World with Dollar Flight Club's Lowest Price for Black Friday Weekend
See how to make money instead of spending it on Black Friday with this offer (Ad)
Arrival, Coupa Software rise; Apple, Activision fall
Inflation hovers over shoppers seeking deals on Black Friday
THE BEST BLACK FRIDAY DEAL YET (Ad)
Mexico's domestic airline industry in shambles
Macao awards casino licenses to MGM, Sands, Wynn, 3 others
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
MarketBeat: Week in Review 11/21 - 11/25
See the World with Dollar Flight Club's Lowest Price for Black Friday Weekend
See how to make money instead of spending it on Black Friday with this offer (Ad)
Arrival, Coupa Software rise; Apple, Activision fall
Inflation hovers over shoppers seeking deals on Black Friday
THE BEST BLACK FRIDAY DEAL YET (Ad)
Mexico's domestic airline industry in shambles
Macao awards casino licenses to MGM, Sands, Wynn, 3 others

Daré Bioscience - DARE Price Target & Analyst Ratings

$0.94
+0.01 (+1.08%)
(As of 11/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.93
$0.94
50-Day Range
$0.89
$1.10
52-Week Range
$0.88
$2.51
Volume
32,199 shs
Average Volume
197,539 shs
Market Capitalization
$79.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Daré Bioscience Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$9.00
857.45% Upside
High Prediction$17.00
Average Prediction$9.00
Low Prediction$4.00
TypeCurrent
11/26/21 to 11/26/22
1 Month Ago
10/27/21 to 10/27/22
3 Months Ago
8/28/21 to 8/28/22
1 Year Ago
11/26/20 to 11/26/21
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$9.00$9.00$9.00$8.00
Predicted Upside857.45% Upside720.42% Upside584.41% Upside349.44% Upside
Get Daré Bioscience Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter.


DARE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DARE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Daré Bioscience Stock vs. The Competition

TypeDaré BioscienceMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.65
2.48
Consensus RatingBuyBuyHold
Predicted Upside857.45% Upside764.02% Upside12.75% Upside
News Sentiment RatingVery Positive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
344
73.19%
Underperform Votes
126
26.81%
Avg. Outperform Votes
164
66.40%
Avg. Underperform Votes
83
33.60%
Avg. Outperform Votes
853
68.19%
Avg. Underperform Votes
398
31.81%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/18/2022HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Douglas Tsao
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$6.00+534.91%
5/13/2022Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jason McCarthy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$4.00+280.95%
4/1/2022Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$11.00 ➝ $17.00+1,037.12%
1/19/2022Brookline Capital Management
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Raja
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
2/15/2021Aegis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Weinstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
7/12/2020Dawson James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$3.00+201.51%
(Data available from 11/26/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












DARE Price Target - Frequently Asked Questions

What is Daré Bioscience's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Daré Bioscience stock is Buy based on the current 3 buy ratings for DARE. The average twelve-month price prediction for Daré Bioscience is $9.00 with a high price target of $17.00 and a low price target of $4.00. Learn more on DARE's analyst rating history.

Do Wall Street analysts like Daré Bioscience more than its competitors?

Analysts like Daré Bioscience more than other Medical companies. The consensus rating score for Daré Bioscience is 3.00 while the average consensus rating score for medical companies is 2.66. Learn more on how DARE compares to other companies.

Do MarketBeat users like Daré Bioscience more than its competitors?

MarketBeat users like Daré Bioscience more than other Medical companies. 73.19% of MarketBeat users gave Daré Bioscience an outperform vote while medical companies recieve an average of 66.40% outperform votes by MarketBeat users.

Does Daré Bioscience's stock price have much upside?

According to analysts, Daré Bioscience's stock has a predicted upside of 720.42% based on their 12-month price targets.

What analysts cover Daré Bioscience?

Daré Bioscience has been rated by HC Wainwright in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:DARE) was last updated on 11/26/2022 by MarketBeat.com Staff